Business Context and Reporting Period
This Form 8-K Current Report was filed by enGene Holdings Inc. (trading symbol: ENGN) on June 10, 2025. The report details the results of the Company's 2025 Annual General Meeting of shareholders held on the same date. The Company is incorporated in British Columbia and is designated as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting; it does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial performance metrics.
Material Changes and Voting Results
The primary material event reported is the shareholder approval of the 2025 Employee Stock Purchase Plan (ESPP) and the election of directors. Key voting statistics include:
- Shareholder Participation: 38,101,263 shares were present or represented by proxy, representing approximately 74.60% of the 51,070,851 outstanding shares entitled to vote.
- Proposal 1 (Election of Directors):
- Gerald Grunk: 30,481,847 votes For; 8,154 votes Withheld.
- Dr. Richard Glickman: 26,312,872 votes For; 4,177,129 votes Withheld.
- Proposal 2 (2025 ESPP Approval): 30,152,713 votes For; 8,427 votes Against; 328,861 votes Abstain. The plan reserves 2,000,000 common shares for issuance.
- Proposal 3 (Auditor Appointment): 38,101,229 votes For; 34 votes Withheld.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors beyond standard corporate governance disclosures. The ESPP is designed to qualify under Section 423 of the Internal Revenue Code of 1986, though the Plan Administrator may determine offerings outside these requirements. The plan became effective on June 10, 2025.
Investor Verification Checklist
- Verify the full terms of the 2025 Employee Stock Purchase Plan in Exhibit 10.1 attached to this filing.
- Review the definitive Proxy Statement filed on May 9, 2025, for detailed descriptions of the director nominees and the ESPP proposal.
- Confirm the number of authorized but unissued common shares available to cover the 2,000,000 shares reserved for the ESPP.
- Note the significant number of broker non-votes (7,611,262) recorded for the director elections and ESPP approval.